Among the acute and chronic lung diseases, pulmonary fibrosis (PF) is the most fatal one
because of its prognosis and treatment is so far an unsuccessful task. In this study, we have …

Pulmonary fibrosis (PF) could severely disrupt the normal lung architecture and function with
fatal consequences. Currently, there is no effective treatment for PF or idiopathic pulmonary …

Idiopathic pulmonary fibrosis is a progressive and lethal form of interstitial lung disease that
lacks effective therapies at present. Glycyrrhizic acid (GA), a natural compound extracted …

Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease of unknown etiology. Recent
investigations have demonstrated that the impaired immune response is a common …

Pulmonary fibrosis is a progressive, irreversible, and fatal fibrotic lung disease with a high
mortality and morbidity, and commonly nonresponsive to conventional therapy. Inula …

Idiopathic pulmonary fibrosis (IPF) is a devastating and common chronic lung disease
pathologically characterized by loss of epithelial cells and activation of fibroblasts and …

Aims Dihydroartemisinin has been shown to inhibit the development of pulmonary fibrosis in
rats, but its mechanism has yet to be elucidated. This study aimed to determine the …

This study aimed to explore the protective effects of a Chinese herbal formula, Jinshui
Huanxian formula (JHF), on experimental pulmonary fibrosis and its underlying …

Introduction Bleomycin (BLM) is a chemotherapeutic agent that is used in the management
of some human cancers such as lymphomas and squamous cell carcinomas. The major …

Pulmonary fibrosis is a devastating lung disorder with mysterious pathogenesis and limited
treatment options. It is well-recognized that the uncontrolled proliferation of lung fibroblasts …